Preclinical pitfalls: How to avoid costly formulation failures - Nature
#Preclinical pitfalls#avoid costly#costly formulation#formulation failures#Nature Preclinical
Life Science News
Latest updates from the biotech and pharma world
Lonza Group First Half 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
#Revenues Beat#Beat Expectations#Yahoo Finance#Lonza Group#Line Yahoo
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
#Vacaville Reporter#Lonza earnings#Vacaville facility#Reporter Vacaville#earnings report
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
#Pharma Letter#Lonza lifts#lifts forecast#performance rebounds#Letter Lonza
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals
#San Francisco#Genentech Vacaville#Francisco Business#Business Times#Business Journals
Lonza tops core profit forecast driven by main drug manufacturing business - Reuters
#Lonza tops#tops core#core profit#profit forecast#forecast driven
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
#Samsung Bio#Lonza posts#Fierce Pharma#pulse check#CDMO pulse
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
#Lonza invest#Pharmaceutical Technology#FDA filing#BioNTech adds#adds CMOs
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
#manufacturing readiness#Lonza leaders#BioSpectrum Asia#gene therapy#Asia Lonza
Strategic planning in ADC development: insights from Lonza - Drug Target Review
#ADC development#Drug Target#Target Review#Lonza Drug#Strategic planning
Lonza chooses TRU Global Solutions for cleanroom services - Cleanroom Technology
#TRU Global#Global Solutions#chooses TRU#Cleanroom Technology#Lonza chooses
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer - Contract Pharma
#Chief Legal#Corporate Affairs#Appoints Andreas#Andreas Bohrer#Affairs Officer
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
#Lonza Confirms#Confirms Strong#call transcript#Earnings call#Investing.com Earnings
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
#Momentum Stock#Great Momentum#Lonza Group#LZAGY#Stock
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com
#Innovation Strategy#Lonza CHI#Future-Ready Capsules#Complex Drugs#Inside Lonza
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
#Pharmaceutical Technology#Lonza focus#mRNA respiratory#respiratory condition#Technology Ethris
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace
#Lonza Collaborate#Respiratory Disease#Disease Prevention#Develop Spray-Dried#mRNA Vaccines
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
#Lonza Collaborate#Contract Pharma#Develop Spray-Dried#mRNA Vaccines#Vaccines Contract
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Lonza Collaborate#Respiratory Disease#Disease Prevention#Develop Spray-Dried
Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook
#Lonza Capsules#Health Ingredients#Nutritional Outlook#Ingredients Nutritional#Outlook Catching